 |
 |
 |
|
 |
|
From 1973 until the present, Prof. Baldeschwieler has been a Professor of Chemistry at CalTech and for five years was also Chairman of the Division of Chemistry and Chemical Engineering. Prof. Baldeschwieler began his distinguished academic research as a member of the faculty at Harvard University. In 1965, Prof. Baldeschwieler moved to Stanford University as Professor of Chemistry. During his last two years at Stanford, Prof. Baldeschwieler was on leave of absence as Deputy Director of the Office of Science and Technology in the White House.
A Fellow of the National Academy of Sciences, American Academy of Arts and Sciences and the American Philosophical Society, Prof. Baldeschwieler has also served on numerous national, scientific and advisory committees, as well as on the editorial boards of several journals. |
 |
|
|
Prof. Baldeschwieler most recently served as Chairman of the Academy Committee on Commercial Aviation Security, as an advisor to the Federal Aviation Administration, as a member of the Presidential Commission on Gulf War Veterans' Illnesses, and the National Academy of Sciences Committee on Science and Technology for Countering Terrorism, and as Co-Chairman of the National Science Foundation-US Intelligence Community Workshop On Approaches to Combating Terrorism.
Prof. Baldeschwieler was a founder of Vestar Inc. and served as Chairman of its Board of Directors until Vestar merged with NeXagen Inc. to form NeXstar Pharmaceuticals. Prof. Baldeschwieler served as a Director of NeXstar until it was acquired by Gilead Pharmaceuticals Inc. Prof. Baldeschwieler was also a founder and Director of Combion Inc. until it was acquired by Incyte Geonomics, Inc. Prof. Baldeschwieler currently serves as a Managing Member of The Athenaeum Fund which is fully invested. He serves as Chairman of the Board of Pasadena Entretec, and as a Director of the Huntington Medical Research Institutes, as well as a director to several privately held companies.
Prof. Baldeschwieler pioneered the utilization of nuclear magnetic resonance and double resonance spectroscopy, nuclear Overhauser effects, ion cyclotron resonance and perturbed angular correlation spectroscopy in chemical problems. The research of Prof. Baldeschwieler concentrated on the use of phospholipid vesicles in cancer diagnosis and therapy, on the development of scanning tunneling and atomic force microscopy for the study of molecules on surfaces, and on novel techniques for producing combinatorial arrays of oligonucleotides. Prof. Baldeschwieler received the National Medal of Science in 2000 for his contributions to science and public service and has also received the American Chemical Society 2001 Award for Creative Invention and the 2003 Othmer Gold Medal of the Chemical Heritage Foundation.
Prof. Baldeschwieler received his undergraduate degree in Chemical Engineering from Cornell University in 1956 and his Ph.D. in 1959 in Physical Chemistry from the University of California, Berkeley. |
|
|
|
 |
